These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1279606)

  • 1. Reverse use dependence of antiarrhythmic class Ia, Ib, and Ic: effects of drugs on the action potential duration?
    Langenfeld H; Köhler C; Weirich J; Kirstein M; Kochsiek K
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2097-102. PubMed ID: 1279606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated mammalian and human cardiac tissues.
    Pankucsi C; Bányász T; Magyar J; Gyönös I; Kovács A; Varró A; Szénási G; Nánási PP
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):398-405. PubMed ID: 9089672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b]quinoline-3,4-dione] in guinea pig cardiac preparations.
    Chang GJ; Su MJ; Kuo SC; Lin TP; Lee YS
    J Pharmacol Exp Ther; 2006 Jan; 316(1):380-91. PubMed ID: 16174797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of the action of class I antiarrhythmic drugs (lidocaine, quinidine, and prajmaline) in rabbit atrial and ventricular myocardium.
    Langenfeld H; Weirich J; Köhler C; Kochsiek K
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):338-45. PubMed ID: 1689432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia and hypoxia/ischaemia.
    MacKenzie I; Saville VL; Waterfall JF
    Br J Pharmacol; 1993 Oct; 110(2):531-8. PubMed ID: 8242227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological effects of propafenone in untreated and propafenone-pretreated guinea-pig atrial and ventricular muscle fibres.
    Delgado C; Tamargo J; Tejerina T
    Br J Pharmacol; 1985 Dec; 86(4):765-75. PubMed ID: 4075015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects.
    Kirchhof PF; Fabritz CL; Franz MR
    Circulation; 1998 Jun; 97(25):2567-74. PubMed ID: 9657478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects on action potential duration of class IA, B and C antiarrhythmic drugs: modulation by stimulation rate and extracellular K+ concentration.
    Campbell TJ; Wyse KR; Pallandi R
    Clin Exp Pharmacol Physiol; 1991 Aug; 18(8):533-41. PubMed ID: 1655321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes.
    Nakaya H; Tohse N; Takeda Y; Kanno M
    Br J Pharmacol; 1993 May; 109(1):157-63. PubMed ID: 7684298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological effects of CI-980, a tubulin binding agent, on guinea-pig papillary muscles.
    Pérez O; Valenzuela C; Delpón E; Tamargo J
    Br J Pharmacol; 1997 Jan; 120(2):187-92. PubMed ID: 9117108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological mapping of regional effects in the rabbit heart of some new antiarrhythmic drugs.
    Millar JS; Vaughan Williams EM
    Br J Pharmacol; 1983 Jul; 79(3):701-9. PubMed ID: 6652350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced post-repolarization refractoriness as an antiarrhythmic principle and its underlying mechanism.
    Franz MR; Gray RA; Karasik P; Moore HJ; Singh SN
    Europace; 2014 Nov; 16 Suppl 4():iv39-iv45. PubMed ID: 25362169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class I and III antiarrhythmic actions of prazosin in guinea-pig papillary muscles.
    Pérez O; Valenzuela C; Delpón E; Tamargo J
    Br J Pharmacol; 1994 Mar; 111(3):717-22. PubMed ID: 8019750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of altered repolarization course induced by antiarrhythmic drugs and constant current pulses on duration of premature action potentials in canine cardiac Purkinje fibers.
    Nakaya Y; Varro A; Elharrar V; Surawicz B
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):908-18. PubMed ID: 2481781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of D-sotalol, quinidine, and amiodarone on dispersion of ventricular repolarization in the isolated rabbit heart.
    Zabel M; Hohnloser SH; Behrens S; Woosley RL; Franz MR
    J Cardiovasc Electrophysiol; 1997 Nov; 8(11):1239-45. PubMed ID: 9395166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of quinidine on repolarization in canine epicardium, midmyocardium, and endocardium: I. In vitro study.
    Sosunov EA; Anyukhovsky EP; Rosen MR
    Circulation; 1997 Dec; 96(11):4011-8. PubMed ID: 9403626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate-dependent class III antiarrhythmic action, negative chronotropy, and positive inotropy of a novel Ik blocking drug, UK-68,798: potent in guinea pig but no effect in rat myocardium.
    Tande PM; Bjørnstad H; Yang T; Refsum H
    J Cardiovasc Pharmacol; 1990 Sep; 16(3):401-10. PubMed ID: 1700210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological characterization of the class III activity of sotalol and its enantiomers. New interpretation of use-dependent effects.
    Hafner D; Berger F; Borchard U; Kullmann A; Scherlitz A
    Arzneimittelforschung; 1988 Feb; 38(2):231-6. PubMed ID: 3370070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dauricine, quinidine, and sotalol on action potential duration of papillary muscles in vitro.
    Guo DL; Zeng FD; Hu CJ
    Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):348-50. PubMed ID: 10072920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.